NanoViricides Inc/ US6300873022 /
| 2024-05-01 10:10:00 PM | Chg. -0.0700 | Volume | Bid10:48:35 PM | Ask10:48:35 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.1300USD | -5.83% | 7,867 Turnover: 7,765.3407 |
1.1300Bid Size: 500 | 1.3500Ask Size: 100 | 1.2300 | 1.1300 |
Newsfile Corp
2021-09-27
NanoViricides, Inc. Invites You to Join Us at the Benzinga Healthcare Small Cap Conference for Updat...
GlobeNewswire
2021-09-14
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and ...
GlobeNewswire
2020-07-21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds NanoViricides (NNVC) Investors of Proprietary Inves...
GlobeNewswire
2020-07-16
NanoViricides, Inc. Investors Who Purchased NNVC Securities After January 2020 And Suffered Losses G...
Newsfile Corp
2020-03-05
NanoViricides, Inc. Reports Discovery of Broad-Spectrum Virus-Binding Ligands; Expected to Counter C...
GlobeNewswire
2019-05-31
Antiviral Therapeutics Markets, Technologies, & Competitive Landscape 2019 Featuring 194 Companies w...
GlobeNewswire
2019-02-26
Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018 - Analysis of Phases, Companies, Mecha...
GlobeNewswire
2019-02-13
Global Antiviral Therapeutics Technologies, Markets & Companies Report 2019: Vaccines, Pharmaceutica...
GlobeNewswire
2018-08-21
President and Chairman of the Board of Directors, Anil R. Diwan, Ph.D., of NanoViricides, Inc., Disc...
GlobeNewswire
2018-05-10
Antiviral Therapeutics Research Report 2018: Technologies, Markets and Companies 2017-2027 - Profile...
